Relief Therapeutics Holding AG (RLFTF)

[Veritas]

Yes, if you are comparing investment choices based on their returns in 6 months from now, and IF you believe that aviptadil will never get any real traction as a cure for Covid due to sufficient population achieving immunity, then RLFTF and the BRPA tickers would all suffer in 6 months from now, and maybe it would be better to sell (if you hold a position) in January or February after some good news. But I don't believe that this will be the case. There is still a lot of time for aviptadil to make its mark on Covid. And, there are so many potential uses for lung conditions with aviptadil that RLF-100 will gain mainstream coverage with the lives that it will be saving, and this will be the springboard to a BP. I will be holding the majority of my RLFTF/BRPAW/BRPA.